| INTRODUCTION
Helicobacter pylori (H. pylori) is a gram-negative and microaerophilic bacterium, which as a kind of common pathogenic bacteria widely spread among the population, especially in developing countries. 1, 2 Over the past 30 years, H. pylori has been recognized as one of the main pathogenic factors in the occurrence and development of gastrointestinal diseases such as gastric cancer, chronic gastritis, peptic ulcer, and gastric mucosa-associated lymphoid tissue (MALT) lymphoma, and it been categorized as the class I carcinogen by World Health Organization. 3, 4 Moreover, H. pylori infection has also been observed to be associated with diseases of nervous system, circulatory system, and blood system.
5-7 Eradication of H. pylori infection is directly related to the prognosis of the aforementioned diseases.
Clinical research studies have demonstrated that H. pylori eradication will uncontroverted benefit those infected patients because it can not only promote gastric mucosa healing but also reduce the main risk factor of MALT lymphoma and gastric cancer. 8, 9 Therefore, H. pylori eradication is of great significance in clinical practice.
Regimens that the combination of proton pump inhibitors (PPIs) and 2 antibiotics as the first-line treatment for H. pylori eradication have been used worldwide in recent years. 10 Unfortunately, the success rate of eradication has been seriously limited for the progressive increase in antibiotic resistance. 11 Thus, in order to determine the status of H. pylori resistance and its patterns in patients and reliably select sensitive antibiotics for clinical use, it is necessary to perform an investigation especially in the absence of individualized H. pylori culture and antibiotic susceptibility test.
In this study, a large sample-based investigation that utilizing drug susceptibility testing for 16 commonly used antibiotics in 5 areas of Zhejiang Province, China, was performed to determine the status of H. pylori resistance and its patterns. Moreover, the resistance rate and the minimal inhibition concentration (MIC) value of antibiotics in different gender groups were also analyzed.
| MATERIALS AND METHODS

| Patient collection and exclusion criteria
Patients in this study were collected from 5 hospitals in 5 areas of 
| Isolation and identification of H. pylori strains
After gastric mucosa biopsy specimen was ground, the homogenate of specimen was inoculated onto modified culture medium (Zhao Tai biotechnology Co., Ltd., Hunan, China). Then, the plate was cultured under a microaerophilic condition (85% nitrogen, 10% carbon dioxide, and 5% oxygen) at 37°C for 2-4 days. were all cultured under a microaerophilic condition at 37°C for 3 days.
| Antibiotic susceptibility test
The resistance breakpoints of each antibiotics are referred to previous reports or the Clinical and Laboratory Standards Institute (CLSI)
guidelines, 13 and showed in Table S1 . NCTC11637 H. pylori strains was used as a positive control. All tests were repeated once.
| Statistical analysis
All statistical analyses in this study were performed with Statistical
Product and Service Solutions (SPSS) 19.0 software (SPSS, Chicago,
IL, USA). Differences of resistance rates in different gender groups
were assessed with the χ 2 test, whereas the MIC value of different groups were assessed with Student's t test. P < .05 was regarded as statistically significant.
| RESULTS
| Determination of resistance in 4 most commonly used antibiotics
Amoxicillin, clarithromycin, levofloxacin, and furazolidone are the most frequently used antibiotics to constitute the first-line treatment for H. pylori eradication in China nowadays. respectively. The resistance rates of clarithromycin and levofloxacin in female group were much higher than those in male group (P = .001 and P < .001, respectively). Similar to resistance rate, the average MIC value of levofloxacin in female group was also larger than that in male group (P < .002). There was no significant difference for amoxicillin and furazolidone in both resistance rate and MIC value.
| Multiple antibiotic resistance
Multidrug resistance is defined as that one bacterial strain is resistant to 2 or more antibiotics. 
| Resistance of H. pylori strains to 12 second-line antibiotics
To obtain more information about the resistance of H. pylori, other 12 second-line antibiotics were tested in 750 strains which are resistant to one of the first-line drugs at least. As shown in Table 3 , the resistance rates of cefetamet, ornidazole, and metronidazole were more than 90%, whereas rifampicin, gentamicin, and doxycycline were still in a low level relatively. The resistance rates of cefetamet (P = .046), azithromycin (P = .009), metronidazole (P = .012), and ciprofloxacin (P < .001) in female group were much higher than those in male group (Table 3) . Only tinidazole resistance rate in female group was lower than that in male group (P = .016, Table 3 ). Moreover, the data showed that there were significant differences in the average MIC value of azithromycin (P = .001), metronidazole (P = .029), ornidazole (P = .049), and tinidazole (P = .017) between male and female group. China were 0.01%-6.8% to amoxicillin, 17.6%-37.5% to clarithromycin, 20.6%-33.5% to levofloxacin, and 0.01%-0.1% to furazolidone. 13, [18] [19] [20] This means China is a highly resistant region of clarithromycin and levofloxacin in H. pylori eradication. Our current data showed that the overall resistance rates of amoxicillin, clarithromycin, levofloxacin, and furazolidone were 1.58%, 22.73%, 24.75%, and 1.49%, respectively (Table 1) . Obviously, compared with the average levels of past, the resistance rate of furazolidone in this region has changed greatly.
| DISCUSSION
Then, other 12 second-line antibiotics were tested in 750 H. pylori strains which are resistant to one of the first-line drugs at least. Our data illustrated that the resistance rates of cefetamet, ornidazole, and metronidazole were more than 90%, whereas rifampicin, gentamicin, and doxycycline were still in a low level relatively (Table 3 ). According to these data, it is reasonable to speculate that rifampicin and gentamicin could be considered as the optional drugs for the treatment of H. pylori eradication in patients with repeated eradication failure.
Antibiotic resistance is closely dependent on its use; and other factors such as age and genders can also affect resistance in clinic. 21, 22 Our current study demonstrated that the resistance rates of clarithromycin, levofloxacin, cefetamet, azithromycin, metronidazole, and ciprofloxacin in female group were much higher than those in male group (Tables 1 and 3) , whereas tinidazole resistance rate in female group was lower than that in male group (Table 3) . Similar to resistance rate, our data also showed that there were significant differences in the average MIC value of levofloxacin, azithromycin, metronidazole, ornidazole, and tinidazole between male and female group (Tables 1 and   3 ). This phenomenon may be related to hormone, genetic differences, and frequency of antibiotic use. Compared with the male group, the female group is more likely to get infectious diseases and more willing to receive antibiotic treatment.
Multiple antibiotic-resistance patterns in H. pylori were observed more frequent in various regions of the world. 23, 24 China also has many similar reports in recent years. 13, 15, 20 In this study, we found that only 64.08% strains were susceptible to all 4 tested antibiotics in our study ( Table 2 ). The rates of double and multiple antibiotic resistance were 11.13% and 12.75% ( 
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